Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy
接受替莫唑胺和放射治疗的胶质母细胞瘤、IDH野生型患者维持Karnofsky功能状态评分(≥50%)的相关因素
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-85339-x
Ohba, Shigeo; Teranishi, Takao; Matsumura, Kazuyasu; Kumon, Masanobu; Kojima, Daijiro; Fujiwara, Eiji; Nakao, Kazutaka; Kuwahara, Kiyonori; Murayama, Kazuhiro; Pareira, Eriel Sandika; Yamada, Seiji; Joko, Masahiro; Nakae, Shunsuke; Muto, Jun; Nishiyama, Yuya; Adachi, Kazuhide; Sasaki, Hikaru; Abe, Masato; Hasegawa, Mitsuhiro; Hirose, Yuichi